Today on Outsourcing-Pharma.com   AstraZeneca axes packaging plant China CRO attracts $30m US investment Synexus agrees to private sale Wacker expands further into biologics Tripos lands Schering-Plough deal

Related Industry News   New drug safety model unveiled as Merck shells out for Vioxx Merck HIV vaccine failure puts cold virus on trial P&G in shock nasal spray exit AstraZeneca CEO hacks at pipeline to up profits

Breaking News on Outsourcing Pharma
Daily  Monday 12 November 2007		Forward to a colleague

	Technical / White Paper Benefits of integrating human tissue research in drug discovery The benefits of integrating human tissue research into drug discovery and development programs are in the confidence that they provide in the selection of the NCEs most likely to succeed in the clinic, and doing this in the most financially efficient way... Click Here Access Full Stories AstraZeneca axes packaging plant AstraZeneca's axe has made its latest appearance in South Africa, with the sale of a packaging plant and the formation of an outsourcing deal with its new owners... Read China CRO attracts $30m US investment China's second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer... Read Synexus agrees to private sale Management of publicly-traded Synexus have agreed to the £18.1m (€25.7m) sale of the company to a private equity firm that has promised to fund its global expansion ventures... Read Wacker expands further into biologics Biopharmaceutical contract manufacturer Wacker will be expanding its German facility in Jena for €15m ($22m) as it meets demand for biologics... Read Tripos lands Schering-Plough deal Tripos Discovery Research (TDR) has risen from the ashes surrounding the liquidation of its previous owners Tripos, Inc. to land a 'library enrichment' deal with Schering-Plough... Read
	All News Headlines for: November | October | September
	Product Brochure Baxter's contract services case study Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization... Click Here
	Related Industry News New drug safety model unveiled as Merck shells out for Vioxx A new 3D model of the human liver that even has its own blood supply could pump new life into drug safety tests by predicting problems earlier and cut down on animal experiments... Read Merck HIV vaccine failure puts cold virus on trial Merck & Co's failed HIV vaccine may actually increase the risk of infection and the latest data raises questions over whether the cold virus used as a delivery technique was at fault... Read P&G in shock nasal spray exit Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no explanation... Read AstraZeneca CEO hacks at pipeline to up profits AstraZeneca's CEO has said the company will stop research in a number of diseases as it continues to cut costs and restructure in the face of falling sales... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Previous Headlines West unscathed by Exubera shot - for now West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the company's... Read Pharmaceutical outsourcing: people on the move INC Research, Quintiles, Bridge Pharmaceuticals, Charles River Laboratories and PharmaNet have all had people on the move in the world of pharmaceutical outsourcing... Read Good news follows bad news for InVentiv After losing a key Novartis contract and getting caught up in the Inyx collapse, Inventiv Health had good news this week when it reported its third quarter results... Read 'World's first' NanoImaging service centre opens NanoImaging Services has opened what it claims is a first of its kind first fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development... Read CROs link arms to spread reach This week two sets of contract research organisations (CROs) have announced plans to link arms in order to spread their reach further into this increasingly globalised marketplace... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com